Silo Pharma, Inc.
SILO
$2.15
-$0.13-5.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -832.80K | -1.65M | -881.50K | -1.11M | -1.20M |
| Total Depreciation and Amortization | 2.90K | 2.90K | 2.90K | 2.90K | 2.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 40.90K | 882.50K | 157.20K | 568.20K | 16.50K |
| Change in Net Operating Assets | 7.10K | -60.90K | -58.90K | -416.20K | -99.90K |
| Cash from Operations | -781.90K | -822.60K | -780.30K | -955.50K | -1.29M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 183.40K | -23.60K | -520.00K | -95.50K | 388.10K |
| Cash from Investing | 183.40K | -23.60K | -520.00K | -95.50K | 388.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 2.13M | 634.90K | 2.09M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -27.00K | -- | -- | -- | -- |
| Cash from Financing | -27.00K | -- | 2.13M | 634.90K | 2.09M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -625.40K | -846.20K | 831.10K | -416.00K | 1.20M |